Abstract:Tumor immunotherapy has gained more and more attention in tumor treatment. However, the accumulation of lactic acid in tumor tissue inhibits the response of immune cells to form an immunosuppressive microenvironment (ISME). To reverse the ISME, an acid-responsive nanoplatform (termed as MLLN@HA) is reported for synergistically enhanced tumor immunotherapy. MLLN@HA is constructed by the co-loading of lactate oxidase (LOX) and DNA repair inhibitor (NU7441) in a manganese-doped layered double hydroxide (Mn-LDH), and then modified with hyaluronic acid (HA) for tumor-targeted delivery. After endocytosis by tumor cells, MLLN@HA decomposes and releases LOX, NU7441 and Mn2+ ions in the acidic tumor microenvironment. The released LOX catalyzes the conversion of lactic acid into hydrogen peroxide (H2O2), which not only alleviates the ISME, but also provides reactants for the Mn2+-mediated Fenton-like reaction to enhance chemodynamic therapy (CDT). Released NU7441 prevents CDT-induced DNA damage from being repaired, thereby increasing double-stranded DNA (dsDNA) fragments within tumor cells. Importantly, the released Mn2+ ions enhance the sensitivity of cyclic GMP-AMP synthase (cGAS) to dsDNA fragments, and activate the stimulator of interferon genes (STING) to induce an anti-tumor immune response. Such an orchestrated immune-boosting strategy ultimately achieves effective tumor growth inhibition and prevents tumor lung metastasis. STATEMENT OF SIGNIFICANCE: To improve the efficacy of tumor immunotherapy, an innovative acid-responsive MLLN@HA nanoplatform was developed for synergistically enhanced tumor immunotherapy. The MLLN@HA actively targets to tumor cells through the interaction of HA with CD44, and then degrades to release LOX, NU7441 and Mn2+ ions in the acidic tumor microenvironment. The released LOX generates H2O2 for the Mn2+-mediated Fenton reaction and reverses the ISME by consuming lactate. NU7441 prevents DNA damage repair, leading to an increased concentration of free DNA fragments, while Mn2+ ions activate the cGAS-STING pathway, enhancing the systemic anti-tumor immune response. The orchestrated immune-boosting nanoplatform effectively inhibits tumor growth and lung metastasis, presenting a promising strategy for cancer treatment.

Lactic acid modified rare earth-based nanomaterials for enhanced radiation therapy by disturbing the glycolysis

Lanthanum-Based Dendritic Mesoporous Nanoplatform for Tumor Microenvironment Activating Synergistic Anti-Glioma Efficacy

Acidity-Activated Charge Conversion of 177 Lu-Labeled Nanoagent for the Enhanced Photodynamic Radionuclide Therapy of Cancer

Interfering Biosynthesis by Nanoscale Metal-Organic Frameworks for Enhanced Radiation Therapy.

Regulating Electron Transportation by Tungsten Oxide Nanocapacitors for Enhanced Radiation Therapy

X-ray triggered pea-shaped LuAG:Mn/Ca nano-scintillators and their applications for photodynamic therapy

X-ray triggered scintillator versatile nanocatalytic platform for synergistic photodynamic/chemodynamic therapy

A manganese-doped layered double hydroxide loaded with lactate oxidase and DNA repair inhibitors for synergistically enhanced tumor immunotherapy

Synergistic cerium oxide nanozymes: targeting DNA damage and alleviating tumor hypoxia for improved NSCLC radiotherapy efficiency

Nanoscale Mixed-Ligand Metal-Organic Framework for X-ray Stimulated Cancer Therapy.

Oxygen‐Evolving Radiotherapy‐Radiodynamic Therapy Synergized with NO Gas Therapy by Cerium‐Based Rare‐Earth Metal‐Porphyrin Framework

A Novel Nanozyme to Enhance Radiotherapy Effects by Lactic Acid Scavenging, ROS Generation, and Hypoxia Mitigation

A Nucleophilicity-Engineered DNA Ligation Blockade Nanoradiosensitizer Induces Irreversible DNA Damage to Overcome Cancer Radioresistance

Calcium Peroxide Nanoparticles Induce Endoplasmic Reticulum Stress for Enhanced Radiation Therapy of Osteosarcoma

Targeting lactate dehydrogenase a improves radiotherapy efficacy in non-small cell lung cancer: from bedside to bench

X-Ray-Induced Nanoparticle-Based Photodynamic Therapy of Cancer

A Mitochondria-Targeted Nanoradiosensitizer Activating Reactive Oxygen Species Burst for Enhanced Radiation Therapy.

Functional LAPONITE Nanodisks Enable Targeted Anticancer Chemotherapy <i>in Vivo</i>

Gold Nanorods Functionalized With Cathepsin B Targeting Peptide And Doxorubicin For Combinatorial Therapy Against Multidrug Resistance

Amplification of oxidative stress with lycorine and gold-based nanocomposites for synergistic cascade cancer therapy

Hierarchical Multiplexing Nanodroplets for Imaging-Guided Cancer Radiotherapy Via DNA Damage Enhancement and Concomitant DNA Repair Prevention